A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.

Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.

Symptoms of Alkaptonuria

The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.

Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.

Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.

Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.

Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.

These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.

How is Alkaptonuria Diagnosed?

Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:

Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.

Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.

Blood Tests: High levels of HGA in the blood can be used as further evidence.

Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.

Management of Alkaptonuria: Is There A Cure?

At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:

Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.

Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.

Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.

Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.

Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.

Life with Alkaptonuria

Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.

Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.

As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.

Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.

New Delhi: Meningitis may not have been the talk of the town, but it is now making headlines after an outbreak in the UK wreaked havoc on students—the outbreak recently resulted in the death of two students, and 11 others have been hospitalised. The outbreak is being linked to a nightclub event in Canterbury, Kent. Following this, the UK Health Security Agency contacted 30,000 students, staff, and their family members, along with anyone who visited the club from March 5 to March 7. This was a precautionary measure, they said, and a new report by UK health officials suggests that meningitis B has caused the outbreak. But what is most shocking is how this infection makes its way into your body.

What is meningitis?

Meningitis is an infection of the protective membranes around the spinal cord and the brain. It can become very serious if not treated or diagnosed in time. It is a consequence of bacterial or viral infection. Despite being a rare occurrence, the infection can spread through coughs, sneezes, a cold, or physical contact in the form of kissing.

Uncommon ways of contracting meningitis

Some of your daily habits may seem normal, but in turn, they can be among the worst ways to catch meningitis. Some of the most obscure ways are:

Vaping: Reminder—vaping might be common now, but that does not make it a safe practice. It is associated with respiratory disorders and even lung collapse in some cases. When it comes to meningitis, vaping can be a means of passing germs on to another person—for instance, by sharing a contaminated vape. The meningococcus bacteria can harmlessly live in the throat without showing any symptoms, but in order to cause damage, it must cross the nasopharyngeal barrier.

Second-hand smoke: Second-hand smoke may not just cause cancer, but also meningitis. This risk is particularly prevalent in children, as it may increase their chances of developing invasive meningococcal disease, a serious form of meningitis. Experts from the University of Nottingham have noted that breathing in smoke from someone else's cigarette can make one more vulnerable to infection. This makes people more likely to harbour meningitis-related bacteria in the throat and nose, thus leading to infection.

Worm infection: Some types of parasites, such as tapeworms, can cause a rare type of meningitis known as eosinophilic meningitis. These worms take residence in the gut and feed on nutrients that the body needs to stay healthy. This can result in diarrhoea, nausea, and tiredness. If the infection spreads to the brain, it can cause meningitis. Despite being rare, it is still a possibility.

Sharing cutlery: Meningitis can spread through close contact, and sharing cutlery can be one of the most overlooked ways. This can also include sharing toothbrushes. The infection can spread through droplets and saliva.

Unwashed hands: An act of laziness can cost you in the long run; therefore, using a sanitiser or regularly washing hands is a must. Experts say that particles from faeces can linger on the hands, and ingesting them in any way can lead to infections such as meningitis. The infection can also spread through coughing and sneezing.

A team of US researchers has developed a novel nasal swab test, akin to those used to detect COVID-19 infections, which can spot early signs of Alzheimer's Disease -- affecting over 55 million people worldwide.

The condition is treatable in early stages to manage symptoms and slow cognitive decline. However, it remains the hardest to detect, affecting treatment outcomes. The brain changes can begin 10 to 20 years before symptoms become apparent.

The novel outpatient nasal swab, developed by Duke University researchers, has shown promise in picking up early biological changes linked to Alzheimer's. It can spot the degenerative condition, even before problems related to thinking and memory begin to appear.

"We want to be able to confirm Alzheimer's very early, before damage has a chance to build up in the brain," said Bradley J. Goldstein, professor at Duke University's School of Medicine.

"If we can diagnose people early enough, we might be able to start therapies that prevent them from ever developing clinical Alzheimer's," Goldstein added.

How Effective Was The Nasal Swab?

In the study, published in the journal Nature Communications, the team placed a gentle swab high inside the nose of 22 participants.

The swab collected thousands of nerve and immune cells to see which genes are active.

The analysis clearly differentiated people with early or diagnosed Alzheimer's from those without the disease -- 81 percent of the time. It also included people with no symptoms.

Alzheimer’s Disease: The Leading Cause of Dementia

Alzheimer's disease is one of the most common forms of dementia and mostly affects adults over the age of 65.

About 8.8 million Indians aged 60 and above are estimated to be living with Alzheimer's disease. Over seven million people in the US, 65 and older, live with the condition, and over 100,00 die from it annually.

Alzheimer's disease is believed to be caused by the development of toxic amyloid and beta proteins in the brain, which can accumulate and damage cells responsible for memory.

While there is no clear cause of Alzheimer's disease, experts believe it can develop due to genetic mutations and lifestyle choices, such as physical inactivity

unhealthy diet

social isolation.

Early symptoms of Alzheimer's disease include forgetting recent events or conversations. Other signs include:

• losing or misplacing things
• getting lost when walking or driving
• being confused, even in familiar places
• losing track of time
• difficulties solving problems or making decisions
• difficulties performing familiar tasks
• misjudging distances to objects visually.

Over time, Alzheimer's disease leads to serious memory loss and affects a person's ability to do everyday tasks.

Currently, there is no cure for this progressive brain disorder, and in advanced stages, loss of brain function can cause dehydration, poor nutrition, or infection. These complications can result in death.

Being physically active and taking part in activities and social interactions that stimulate the brain and maintain daily function can help prevent the condition.

The Human papillomavirus (HPV) vaccine is one of the most important advances in preventive healthcare, with the unique ability to prevent cancers.

Evidence consistently shows that the most appropriate age for HPV vaccination is between 9 and 14 years. At this stage, children develop a significantly stronger immune response, producing higher antibody titers than older adolescents and adults.

This enhanced immunogenicity translates into durable and highly effective protection and also allows simplified schedules, including the possibility of single-dose protection, thereby improving feasibility and coverage at a population level.

HPV Vaccine: Why Age 14 Matters The Most

The emphasis on vaccination by the age of 14 years is particularly important. Beyond this age, the immune response is relatively lower, and the number of doses required increases, making early vaccination both scientifically and programmatically more efficient.

Recognizing this, the Government of India has adopted a strategy of administering a single-dose HPV vaccine to adolescents up to 14 years of age through school- and community-based outreach programs. The program utilizes the Gardasil vaccine, which has an established track record of safety and efficacy over nearly two decades.

Equally critical is the timing of vaccination in relation to exposure. HPV is primarily transmitted through sexual contact, and vaccination before exposure ensures maximum effectiveness. Administering the vaccine in early adolescence provides protection well before any potential risk, making it a true preventive intervention with near-complete benefit.

Persistent infection with high-risk HPV types is a well-established cause of several cancers. In India, cervical cancer continues to be one of the leading causes of cancer-related illness and death among women. While HPV is also responsible for anal, penile, and oropharyngeal cancers, the burden of cervical cancer is substantially higher, which has historically led to a greater focus on vaccinating girls.

HPV: Are Boys At Risk?

However, HPV infection affects both genders. Boys are also at risk of HPV-related diseases, including anal and penile cancers, genital warts, and oropharyngeal cancers, the incidence of which is rising globally.

Vaccinating boys offers direct protection to them and also contributes to reducing transmission within the community. A broader, gender-inclusive approach has the potential to enhance population-level protection.

Public health agencies, including the World Health Organization, have emphasized HPV vaccination as a key strategy in cancer prevention and in reducing the long-term burden of non-communicable diseases.

HPV Vaccine: Part of Adolescent Health Check-ups

Integrating HPV vaccination into routine adolescent health check-ups can further normalize it as a standard preventive health measure. This approach can complement government efforts by encouraging participation from the private healthcare sector and improving overall uptake.

HPV vaccination in the 9–14 year age group is therefore not merely a recommendation; it is a time-sensitive, evidence-based intervention that can prevent cancers decades later. Strengthening awareness and ensuring timely vaccination will be critical in reducing the future burden of HPV-related cancers in India.